Friday, March 13, 2009

Phase IV Services

ClinAsia clinical experience in product development ensures collaboration and integration from pre-approval to post-approval. We provide a custom-tailored process, fine-tuned across the globe, to meet local regulatory requirements. Our operational model is based on a robust technology platform to support remote centralized management of our clients' sites, and our operating procedures are designed for a post-approval setting.








Early Post-Approval Planning

ClinAsia team helps its client in post approval planning in manufacturing and go to market strategies.

Product Safety and Pharmacovigilance

The team has extensive experience in the collection of safety information for more than 100 products, covering a broad spectrum of therapeutic areas.

Late Stage Research Services

ClinAsia team has helped clients develop and implement late-stage research, including registries and observational studies for more than 10 years.

Registries and Observational Studies

ClinAsia can help in maintaining registries and conduct observational studies once the product has been approved.

www.clinasia.com

No comments:

Post a Comment